Tevogen Bio develops T-cell therapies for infectious diseases, cancers, and neurological disorders. Read why I've initiated a small position in TVGN stock.
Gilead Sciences is working with AI-powered biotechnology company Terray Therapeutics to use artificial intelligence to discover and develop small-molecule therapies across multiple targets.